Patent Yard Sign in
Canadian application, no grantCanada

Treatment of infertility

CA 2363074 A1 · Owner: Novo Nordisk A/S · Inventors: Grondahl, Christian

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

In an in vitro fertilisation method, a woman is treated with a hypothalamic hormone and/or a pituitary hormone or an agonist or antagonist thereof or an active derivative thereof for a short period of time and thereafter, using in , vitro oocyte maturation egg or eggs are retrieved from the woman and are maturated using a meiosis activating compound.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed February 23, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 23, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 23, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledFebruary 23, 2000
GrantedNo grant recorded
Term endedFebruary 23, 2020
Patent numberCA 2363074 A1
Classification (IPC)A61K38/24 +2 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedFeb 23, 2000Term endedFeb 23, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.